AEROBACTER AEROGENES TYPE III
AEROBACTER AEROGENES TYPE III structure
|
Common Name | AEROBACTER AEROGENES TYPE III | ||
|---|---|---|---|---|
| CAS Number | 68583-24-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
|
RU 41 740 (Biostim) and IL-4, or IL-13, have opposite effects on CD14, CD23, HLA-DR and HLA-DQ on monocytes.
Int. J. Immunopharmacol. 18(1) , 69-74, (1996) RU 41 740 (Biostim) is a glycoprotein extract obtained from Klebsiella pneumoniae. Its immunostimulating properties on monocytes have been established in vivo and in vitro. To confirm its spectrum of action at molecular level we studied its role on the modula... |
|
|
RU 41740 (Biostim) stimulates the production of granulocyte macrophage colony-stimulating factor and interleukin-8 by human bronchial epithelial cells in vitro.
Gen. Pharmacol. 27(8) , 1351-3, (1996) 1. In this study, we observed the effects of RU 41740 (Biostim) on the production of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-8 (IL-8) in human bronchial epithelial cells in vitro. 2. Cytokine production was assessed by enzyme... |
|
|
Preventive role of lyophilic dairy products bulgaricum and biostim.
Cancer Lett. 114(1-2) , 93-5, (1997) The purpose of the study was to examine the protective role of lyophilic dairy products bulgaricum and biostim with active bacteria lactic acid strain. Protective effect was determined as a phagocytosis activity and activity of major immunoglobulins. In total... |
|
|
The immunostimulant RU41740 from Klebsiella pneumoniae activates human cells in whole blood to potentially stimulate innate and adaptive immune responses.
Int. Immunopharmacol. 6(4) , 635-46, (2006) The compound RU41740 from Klebsiella pneumoniae, when used as an immunostimulant, improves responses to bacterial and yeast infections in murine models and in human trials. The aim of this study was to determine in vitro, the capacity of RU41740 to stimulate ... |
|
|
The effects of RU 41.740, a glycoprotein immunomodulating agent derived from Klebsiella pneumoniae, on intra-abdominal abscess formation in mice.
J. Med. Microbiol. 38(6) , 454-8, (1993) The prophylactic and therapeutic efficacies of the immunomodulating agent RU 41.740 (a glycoprotein extract from Klebsiella pneumoniae) were studied in a murine model of intra-abdominal abscess formation with Bacteroides fragilis, Escherichia coli, and bran a... |
|
|
The immunomodulating agent RU 41740 complexed with very-low-density lipoproteins enhances human polymorphonuclear neutrophil oxidative metabolism in vitro.
Pharmacology 46(6) , 341-5, (1993) Added to human serum in vitro, RU 41740, an immunomodulating agent extracted from Klebsiella pneumoniae, binds selectively to lipoproteins containing apolipoprotein B (low-density lipoproteins and very-low-density lipoproteins, VLDL) and, at higher concentrat... |
|
|
Effect of an immunomodulating agent, RU 414740, on polymorphonuclear responsiveness after burn injury.
Inflammation 15(6) , 437-45, (1991) An impairment of polymorphonuclear leukocyte (PMN) functions has been described following burn trauma. It was thus of interest to investigate the effect of RU 41740, an agent known to stimulate these cells, on rat PMN functions after burn injury. In the prese... |
|
|
[Is it wrong to use immunostimulants in pediatric practice?].
Arch. Pediatr. 6 Suppl 2 , 427s-428s, (1999)
|
|
|
[Biostim (glycoprotein extracted from Klebsiella pneumoniae)-induced Bullous pemphigoid].
Therapie. 59(2) , 270-1, (2004)
|
|
|
Determination of the antiinfectious activity of RU 41740 (Biostim) as an example of an immunomodulator.
Adv. Exp. Med. Biol. 319 , 165-74, (1992) Evaluation of the anti-infectious activity of an immunomodulator performed either in vitro or in vivo in animals as in humans must answer three questions: what are the targets? what models should be used to study the mechanism of action? what methodology shou... |